Skip to content
Brand AI

Baxter International

Recent events

Recent events tied to this brand in public sources.

Back to profile3 entries

  1. 2021

    FDA approves Baxter’s premix norepinephrine formulation

    The U.S. Food and Drug Administration approved Baxter’s premix Norepinephrine Bitartrate in 5% Dextrose Injection formulation.

    Source

  2. 2021

    Baxter commercially launches premix norepinephrine formulation

    Baxter commercially launched its ready-to-use premix Norepinephrine Bitartrate in 5% Dextrose Injection formulation, which is available in the U.S.

    Source

  3. 2021

    Baxter partners with Moderna on vaccine manufacturing

    Baxter International and its BioPharma Solutions division partnered with Moderna to provide fill/finish sterile manufacturing services and packaging for approximately 60–90 million doses of Moderna's COVID-19 vaccine in 2021.

    Source